Drug discovery is maturing. Researchers are increasingly focusing on challenging targets, including beyond Rule of 5 (bRo5) compounds, to achieve previously intractable therapeutic opportunities. Simultaneously, they’re under growing pressure to make reliable ADMET predictions in chemical spaces where many conventional models perform poorly.

This evolution requires predictive modeling platforms that can keep up.

Join us for our next webinar to learn what ADMET Predictor® 14 enables you to do. Dr. Jeremy Jones, Principal Scientist, and Dr. David Miller, Engineering Fellow, will describe several newly added predictive models, the updating of existing models to better cover bRo5 space, and key improvements to the high-throughput pharmacokinetic (HTPK) simulation module, command line and REST API, in addition to a new command-line version of ADMET Modeler.

They will also provide a preview of the new Simulations Plus AI-enabled platform that seamlessly combines a natural-language prompt interface with our powerful ADMET Predictor engine.

Register now to attend and get a link to the recording.

Presenters

• Jeremy Jones, Ph.D., Principal Scientist, Simulations Plus
• David Miller, Ph.D., Engineering Fellow, Simulations Plus

Moderator

• Tom Sanderson, Business Development Director, Simulations Plus